What is pneumococcal Bacteremia?

Older age, along with conditions such as septic arthritis, endocarditis, and pneumonia, are factors significantly associated with complicated pneumococcal bacteremia, according to data presented at IDWeek, which took place from October 19 to October 22, 2025, in Atlanta, Georgia.¹

[Image of Bacteria and viruses in bloodstream, infection and immune system response medical concept. | Image Credit: © Iryna – stock.adobe.com]

Pneumococcal bacteremia occurs when the bacteria causing pneumococcal disease,Streptococcus pneumoniae enters the bloodstream. It most often occurs in immunocompetent and immunosuppressed patients, and although it can begin as a primary infection, it is one of the most common manifestations of invasive pneumococcal disease (IPD).^2,3

Treatment for pneumococcal bacteremia can be tough because of a lack of localized symptoms and indications of infection; however, concern lies with where the infection has spread.This distinction separates uncomplicated from complicated pneumococcal bacteremia, with the former encompassing patients without an uncontrolled infection source requiring treatment longer than 2 weeks. Contrastingly, patients with complicated pneumococcal bacteremia may face deep-seated infections spreading to the bones, lungs, or joints.^2-4

Especially severe complicated bacteremia can induce sepsis and septic shock or cause infections in distant sites, such as meningitis, endocarditis, and septic arthritis. The case-fatality rate for pneumococcal bacteremia hovers around 20%, but depending on age and comorbidities, it could be as high as 60%.Prompt treatment is essential because the risk of death is highest within the

Understanding Risks of Pneumococcal Bacteremia

Research shows that certain things increase the risk of getting seriously sick from pneumococcal bacteremia. Being older is a major risk factor for severe illness. Pharmacists should talk to older patients about how pneumococcal vaccines can help prevent both invasive pneumococcal disease (IPD) and bacteremia.¹

REFERENCES

1. Jayawardena R, Gill CM, Chamberland RR, Poowanawittayakom N. (P-53) Analyzing the risks of complicated S. pneumoniae bacteremia: Community vaccine uptake and preventive measures in real-world scenarios. Presented: IDWeek; October 20, 2025; Atlanta, GA. Accessed via IDWeek Virtual Platform on November 20, 2025.

2. Disease details about pneumococcal disease. European Center for Disease Prevention and Control. Last Updated November 28, 2023. Accessed November 20, 2025. european Centre for Disease Prevention and Control.